Vibration threshold in non-diabetic subjects

Svea Nolte, Marco van Londen, Jan Willem J Elting, Bianca T A de Greef, Jan B M Kuks, Catharina G Faber, Ilja M Nolte, Rob J M Groen, Stephan J L Bakker, Dion Groothof, Ivonne Lesman-Leegte, Stefan P Berger, Gea Drost, Svea Nolte, Marco van Londen, Jan Willem J Elting, Bianca T A de Greef, Jan B M Kuks, Catharina G Faber, Ilja M Nolte, Rob J M Groen, Stephan J L Bakker, Dion Groothof, Ivonne Lesman-Leegte, Stefan P Berger, Gea Drost

Abstract

Measuring vibration perception threshold (VPT) accurately classifies and quantifies the severity of loss of vibration perception. A biothesiometer (Bio-thesiometer®; Bio Medical Instrument Co, Ohio, USA) appears to be the most suitable tool to determine VPT due to its low inter-rater variability and low occurence of adaption to the sensation. Different VPT values for a biothesiometer have been described, however, specification on age, height and different measurement locations is currently lacking. The objective of our study was to identify determinants of vibration perception in non-diabetic subjects, in order to provide individualized normal values of VPTs for clinical practice. Measurements of the vibration perception were performed on the big toes, insteps, lateral malleoli, and wrists. A total of 205 healthy subjects were included (108 (52.7%) males) with a median [interquartile range] age of 59 [51;64] (range 21-80) years. Mean height was 174.45 ± 9.20 cm and mean weight was 82.94 ± 14.84 kg, resulting in a mean BMI of 27.19 ± 4.00 kg/m2. In stepwise forward linear regression analyses, age (st. β = 0.51, p < 0.001) and height (st. β = 0.43, p < 0.001) were found to be the independent unmodifiable determinants of the VPT at the big toe. Regression coefficients for quantiles of the determinants age and height were incorporated in the corresponding regression equations. This study provides equations to calculate age- and height-specific normal values for VPT that can be used in clinical practice and in large research studies.

Trial registration: ClinicalTrials.gov NCT03272841.

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1. Participants.
Fig 1. Participants.
Fig 2. Measured points (big toe, instep,…
Fig 2. Measured points (big toe, instep, lateral malleolus, wrist).
Fig 3. Measurement.
Fig 3. Measurement.
Fig 4. VPT against age for big…
Fig 4. VPT against age for big toes, insteps, lateral malleoli, and wrists.
Fig 5. VPT against height for big…
Fig 5. VPT against height for big toes, insteps, lateral malleoli, and wrists.
Fig 6. Conditional quantiles of VPT as…
Fig 6. Conditional quantiles of VPT as a function of age for different measurement locations.
Conditional quantiles were modelled flexibly using natural cubic splines of age with two degrees of freedom. Natural boundary conditions were imposed on the 2.5% and 97.5% quantiles of age. The specific quantiles associated with either of the lines is indicated on the right-hand edge of the line. The height across the participants is depicted as a color gradient, with lower values of height given in blue and higher values in red.
Fig 7. Conditional quantiles of VPT as…
Fig 7. Conditional quantiles of VPT as a function of height for different measurement locations.
Conditional quantiles were modelled flexibly using natural cubic splines of height with two degrees of freedom. The specific quantiles associated with either of the lines is indicated on the right-hand edge of the line. The age across the participants is depicted as a color gradient, with lower values of age given in blue and higher values in red.

References

    1. Tenckhoff HA, Boen FST, Jebsen RH, Spiegler JH. Polyneuropathy in Chronic Renal Insufficiency. JAMA. 1965;192:1121–4. 10.1001/jama.1965.03080260009003
    1. Martina IS, van Koningsveld R, Schmitz PI, van Der Meché FG, van Doorn PA. Measuring Vibration Thresholds with a Graduated Tuning Fork in Normal Aging and in Patients with Polyneuropathy. European Inflammatory Neuropathy Cause and Treatment (INCAT) group. J Neurol Neurosurg Psychiatry. 1998;65(5):743–7. 10.1136/jnnp.65.5.743
    1. Marcuzzi A, Wainwright AC, Costa DSJ, Wrigley PJ. Vibration Testing: Optimising Methods to Improve Reliability. Muscle Nerve. 2019;59(2):229–35. 10.1002/mus.26373
    1. Bio-Medical Instrument Company. Bio-Thesiometer: Instructions for Operation.
    1. Bloom S, Till S, Sönksen P, Smith S. Use Of A Biothesiometer To Measure Individual Vibration Thresholds And Their Variation In 519 Non-Diabetic Subjects. Br Med J (Clin Res Ed). 1984;288(6433):1793–5.
    1. Callaghan BC, Price RS, Feldman EL. Diagnostic and Therapeutic Advances: Distal Symmetric Polyneuropathy. JAMA. 2015;314(20):2172–81.
    1. Maffei L, Premrou V, Roldan P, Copetti M, Pellegrini F, Rossi MC, et al. Vibration Perception Threshold in the Screening of Sensorimotor Distal Symmetric Polyneuropathy: The Need of More Accurate Age-Specific Reference Values. J Diabetes Sci Technol. 2014;8(3):621–2. 10.1177/1932296814527818
    1. Roos D. The Vibration Perception Threshold in Gastrectomized Patients with Low Serum B12. A Clinical and Biothesiometric Follow-up after Intensive B12 Therapy. Acta Neurol Scand. 1977;56(6):551–62. 10.1111/j.1600-0404.1977.tb01460.x
    1. Kerner W, Brückel J. Classification And Diagnosis of Diabetes Mellitus. Exp Clin Endocrinol Diabetes. 2014;122(7):384–6. 10.1055/s-0034-1366278
    1. Eisenga MF, Gomes-Neto AW, van Londen M, Ziengs AL, Douwes RM, Stam SP, et al. Rationale and design of TransplantLines: a prospective cohort study and biobank of solid organ transplant recipients. BMJ Open. 2018;8(12):e024502 10.1136/bmjopen-2018-024502
    1. Svendsen TK, Kroigard T, Wirenfeldt M, Schroder HD, Bak S, Möller S, et al. Statin Use and Peripheral Nerve function—A Prospective Follow-Up Study. Basic Clin Pharmacol Toxicol. 2019: 10.1111/bcpt.13320 .
    1. Warendorf JK, Vrancken AFJE, van Eijk RPA, Visser NA, van den Berg LH, Notermans NC. Statins Do Not Increase Risk of Polyneuropathy: A Case-Control Study and Literature Review. Neurology. 2019;92(18):e2136–e2144. 10.1212/WNL.0000000000007148
    1. Stavros K, Simpson DM. Understanding the Etiology and Management of HIV-associated Peripheral Neuropathy. Curr HIV/AIDS Rep. 2014;11(3):195–201. 10.1007/s11904-014-0211-2
    1. Furno M. Goodness of Fit and Misspecification in Quantile Regressions. J Educ Behav Stat. 2011;36(1):105–31.
    1. Shirk SD, Mitchell MB, Shaughnessy LW, Sherman JC, Locascio JJ, Weintraub S, et al. A Web-Based Normative Calculator for the Uniform Data Set (UDS) Neuropsychological Test Battery. Alzheimers Res Ther. 2011;3(6):32 10.1186/alzrt94
    1. Sherwood B, Zhou AX, Weintraub S, Wang L. Using Quantile Regression to Create Baseline Norms for Neuropsychological Tests. Alzheimers Dement (Amst). 2015;2:12–8.
    1. Rogers WH. Quantile Regression Standard Errors. Stata Tech Bull. 1992;9:16–19.
    1. Koo TK, Li MY. A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research. J Chiropr Med. 2016;15(2):155–63. 10.1016/j.jcm.2016.02.012
    1. Jones G, Barker A. Reference Intervals. Clin Biochem Rev. 2008; 29(Suppl 1):S93–S97.
    1. Pearson GHJ. Effect of Age on Vibratory Sensibility. Arch Neurol Psychiatry. 1928;20:482–96.
    1. Meh D, Denislic M. Influence of Age, Temperature, Sex, Height and Diazepam on Vibration Perception. J Neurol Sci. 1995;134(1–2):136–42. 10.1016/0022-510x(95)00230-9
    1. Tjon-A-Tsien AM, Van Dijk JG, Van Der Velde EA, Kamzoul BA, Lemkes HH. Determinants of Vibration Perception Thresholds in IDDM and NIDDM Patients. Diabetes Res Clin Pract. 1995;27(3):211–9. 10.1016/0168-8227(95)01049-j
    1. Lin YH, Hsieh SC, Chao CC, Chang YC, Hsieh ST. Influence of Aging on Thermal and Vibratory Thresholds of Quantitative Sensory Testing. J Peripher Nerv Syst. 2005;10(3):269–81. 10.1111/j.1085-9489.2005.10305.x
    1. Deshpande N, Metter EJ, Ling S, Conwit R, Ferrucci L. Physiological Correlates of Age-Related Decline in Vibrotactile Sensitivity. Neurobiol Aging. 2008;29(5):765–73. 10.1016/j.neurobiolaging.2006.12.002
    1. Verrillo RT. Age Related Changes in the Sensitivity to Vibration. J Gerontol. 1980;35(2):185–93. 10.1093/geronj/35.2.185
    1. Cerimele D, Celleno L, Serri F. Physiological Changes in Ageing Skin. Br J Dermatol. 1990;122 Suppl 35:13–20.
    1. Paré M, Albrecht PJ, Noto CJ, Bodkin NL, Pittenger GL, Schreyer DJ, et al. Differential Hypertrophy and Atrophy among All Types of Cutaneous Innervation in the Glabrous Skin of the Monkey Hand during Aging and Naturally Occurring Type 2 Diabetes. J Comp Neurol. 2007;501(4):543–67. 10.1002/cne.21262
    1. Knox CA. Neuroanatomical Changes Associated with Aging in the Peripheral Nervous System In: Albert ML, Knoefel JE, editors. Clinical neurology of aging. 2nd ed New York: Oxford University Press; 1994. pp. 68–78.
    1. Sorond FA, Cruz-Almeida Y, Clark DJ, Viswanathan A, Scherzer CR, De Jager P, et al. Aging, the Central Nervous System, and Mobility in Older Adults: Neural Mechanisms of Mobility Impairment. J Gerontol A Biol Sci Med Sci. 2015;70(12):1526–32. 10.1093/gerona/glv130
    1. Shaffer SW, Harrison AL. Aging of the Somatosensory System: A Translational Perspective. Phys Ther. 2007;87(2):193–207. 10.2522/ptj.20060083
    1. Rinkel WD, Hosein Aziz M, Van Deelen JM, Williamson SP, Castro Cabezas M, Van Neck JW, et al. Normative data for cutaneous threshold and spatial discrimination in the feet. Muscle & Nerve. 2017;56(3):399–407.
    1. NCD Risc Factor Collaboration (NCD-RisC). A Century of Trends in Adult Human Height. Elife. 2016;5:e13410 10.7554/eLife.13410
    1. Shy ME, Frohman EM, So YT, Arezzo JC, Cornblath DR, Giuliani MJ, et al. Quantitative Sensory Testing: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2003;60(6):898–904. 10.1212/01.wnl.0000058546.16985.11
    1. Visser NA, Notermans NC, Linssen RS, Van Den Berg LH, Vrancken AF. Incidence of Polyneuropathy in Utrecht, the Netherlands. Neurology. 2015;84(3):259–64. 10.1212/WNL.0000000000001160
    1. Teunissen LL, Eurelings M, Notermans NC, Hop JW, Van Gijn J. Quality of Life in Patients with Axonal Polyneuropathy. J Neurol. 2000;247(3):195–9. 10.1007/s004150050562

Source: PubMed

3
Subscribe